高脚酒杯
发表于 2025-3-23 13:04:21
Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy,n several crucial molecular pathways that support the proliferative potential of CLL. Since molecules in these pathways can contribute to proliferation, survival and chemoresistance of CLL, they are potentially useful therapeutic targets. We discussed promising methods that have been developed to ta
Palliation
发表于 2025-3-23 15:06:46
http://reply.papertrans.cn/43/4256/425544/425544_12.png
Grasping
发表于 2025-3-23 21:30:32
Myelodysplastic Syndromes,0 it now approaches 75 per 100,000 (Cogle et al. 2011). Men are affected at a somewhat higher rate than women. There is no apparent geographical bias to the distribution of MDS; on an age-adjusted basis, the incidence is similar throughout the world, although it should be noted that these studies we
triptans
发表于 2025-3-23 23:14:25
http://reply.papertrans.cn/43/4256/425544/425544_14.png
mendacity
发表于 2025-3-24 03:11:50
http://reply.papertrans.cn/43/4256/425544/425544_15.png
Hippocampus
发表于 2025-3-24 07:14:30
Epigenetic Regulation and Therapy in Lymphoid Malignancies,cologically reversible, they have been regarded as optimal targets for what is now known as epigenetic therapy. In this review, we will discuss our current understanding of normal epigenetic processes, outline our knowledge of epigenetic alterations, discuss advances in the understanding of post-tra
lymphedema
发表于 2025-3-24 10:49:51
B Cell Growth, Differentiation and Malignancies,teria, viruses and other foreign insults to the human body. Each B cell makes only one distinct immunoglobulin which recognizes a cognate antigen. It is estimated that B cells in the human body can produce as many as 10. different antibodies. Thus, each B cell must undergo a series of differentiatio
难理解
发表于 2025-3-24 16:33:19
Follicular Lymphoma: Recent Advances,astic follicles that resemble the normal GC. Normal GCB-cells do not express the anti-apoptotic protein B-cell leukemia/lymphoma 2 (BCL2) and they readily undergo apoptosis if they do not have a high affinity antigen receptor that will transmit survival signals on recognition of the antigen. The vas
absorbed
发表于 2025-3-24 21:15:00
Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy,r symptoms for a long period of time and require no treatment. However, malignant progression of CLL strikes indefinitely in some patients, and such CLL responds poorly to conventional chemotherapies and will eventually acquire chemoresistance. Currently, no efficient therapeutic options are availab
overwrought
发表于 2025-3-24 23:26:02
http://reply.papertrans.cn/43/4256/425544/425544_20.png